Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …

In recent years, tremendous advancements in nanomedicine have resulted in the rapid
development of various nanoformulations, especially the treatment of solid tumors. Despite …

Glioblastoma is one of the most aggressive central nervous system malignancies with high
morbidity and mortality. Current clinical approaches, including surgical resection …

Hypoxia is a common hallmark of human disease that is characterized by abnormally low
oxygen levels in the body. While the effects of hypoxia on many small molecule-based drugs …

Messenger RNA (mRNA)‐based therapy has emerged as a powerful, safe, and rapidly
scalable therapeutic approach that involves technologies for both mRNA itself and the …

Approved anticancer drugs typically face challenges due to their narrow therapeutic window,
primarily because of high systemic toxicity and limited selectivity for tumors. Prodrugs are …

Early lung cancer screening by computed tomography is hampered by pulmonary nodules
caused by massive COVID‐19 infections, necessitating an ultrasensitive approach for the …

Glioma is the most common primary intracranial tumor, which is formed by the malignant
transformation of glial cells in the brain and spinal cord. It has the characteristics of high …

Previous studies have shown that major depressive disorder (MDD) patients exhibit
structural and functional impairments, but few studies have investigated changes in higher …

Owing to their elemental abundance and unique bandgap, ternary transition metal
chalcogenides (TMCs) have recently attracted significant attention from researchers. Among …